Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Mehta

Showing results (1011-1020 of 1,216) with videos related to

Pageof 122
Sort By:
International Journal of Radiation Oncology, Biology, Physics|May 7, 2017
A Multi-institutional Analysis of Trimodality Therapy for Esophageal Cancer in Elderly PatientsScott C Lester, Steven H Lin, Michael Chuong, et al.
Lancet (London, England)|May 26, 2004
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trialDavid W Andrews, Charles B Scott, Paul W Sperduto, et al.
Anticancer Research|June 10, 2019
Defining an Intermediate-risk Group for Low-grade Glioma: A National Cancer Database AnalysisVikram Jairam, Benjamin H Kann, Henry S Park, et al.
Journal of Neuro-Oncology|February 16, 2015
Veliparib in combination with whole brain radiation therapy in patients with brain metastases: results of a phase 1 studyMinesh P Mehta, Ding Wang, Fen Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|March 30, 2025
Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy in One Fraction: A Multicenter, Single-Arm, Phase 2 TrialMichael D Chuong, Kathryn E Mittauer, Michael F Bassetti, et al.
Clinical Neuropathology|December 1, 2018
ATRX protein loss and deregulation of PI3K/AKT pathway is frequent in pilocytic astrocytoma with anaplastic featuresAdriana Olar, Diep Tran, Vidya P Mehta, et al.
Bioorganic & Medicinal Chemistry|October 15, 2003
Discovery of novel benzothiazolesulfonamides as potent inhibitors of HIV-1 proteaseSrinivasan R Nagarajan, Gary A De Crescenzo, Daniel P Getman, et al.
Physiological Genomics|July 5, 2012
Evidence for an early endometrial response to pregnancy in cattle: both dependent upon and independent of interferon tauN Forde, G B Duffy, P A McGettigan, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2013
A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320Paul W Sperduto, Meihua Wang, H Ian Robins, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|March 2, 2024
Clinical application of an institutional fractionated stereotactic radiosurgery (FSRS) program for brain metastases delivered with MRIdian<sup>Ⓡ</sup> BrainTx™Alonso La Rosa, Kathryn E Mittauer, Nema Bassiri, et al.
Pageof 122

Showing results (1011-1020 of 1,216) with videos related to

Sort By:
Pageof 122
International Journal of Radiation Oncology, Biology, Physics|May 7, 2017
A Multi-institutional Analysis of Trimodality Therapy for Esophageal Cancer in Elderly PatientsScott C Lester, Steven H Lin, Michael Chuong, et al.
Lancet (London, England)|May 26, 2004
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trialDavid W Andrews, Charles B Scott, Paul W Sperduto, et al.
Anticancer Research|June 10, 2019
Defining an Intermediate-risk Group for Low-grade Glioma: A National Cancer Database AnalysisVikram Jairam, Benjamin H Kann, Henry S Park, et al.
Journal of Neuro-Oncology|February 16, 2015
Veliparib in combination with whole brain radiation therapy in patients with brain metastases: results of a phase 1 studyMinesh P Mehta, Ding Wang, Fen Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|March 30, 2025
Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy in One Fraction: A Multicenter, Single-Arm, Phase 2 TrialMichael D Chuong, Kathryn E Mittauer, Michael F Bassetti, et al.
Clinical Neuropathology|December 1, 2018
ATRX protein loss and deregulation of PI3K/AKT pathway is frequent in pilocytic astrocytoma with anaplastic featuresAdriana Olar, Diep Tran, Vidya P Mehta, et al.
Bioorganic & Medicinal Chemistry|October 15, 2003
Discovery of novel benzothiazolesulfonamides as potent inhibitors of HIV-1 proteaseSrinivasan R Nagarajan, Gary A De Crescenzo, Daniel P Getman, et al.
Physiological Genomics|July 5, 2012
Evidence for an early endometrial response to pregnancy in cattle: both dependent upon and independent of interferon tauN Forde, G B Duffy, P A McGettigan, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2013
A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320Paul W Sperduto, Meihua Wang, H Ian Robins, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|March 2, 2024
Clinical application of an institutional fractionated stereotactic radiosurgery (FSRS) program for brain metastases delivered with MRIdian<sup>Ⓡ</sup> BrainTx™Alonso La Rosa, Kathryn E Mittauer, Nema Bassiri, et al.
Pageof 122